Form 8-K - Current report:
SEC Accession No. 0001628280-25-045239
Filing Date
2025-10-16
Accepted
2025-10-16 17:02:13
Documents
18
Period of Report
2025-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gral-20251016.htm   iXBRL 8-K 49783
2 EX-10.1 exhibit101spa-grailxsamsun.htm EX-10.1 455695
3 EX-99.1 ex991pressreleasedatedocto.htm EX-99.1 29691
7 image_0a.jpg GRAPHIC 3501
8 screenshot2025-10x15at5002.jpg GRAPHIC 403962
9 screenshot2025-10x15at5005.jpg GRAPHIC 302105
10 screenshot2025-10x15at5044.jpg GRAPHIC 432966
  Complete submission text file 0001628280-25-045239.txt   2321326

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gral-20251016.xsd EX-101.SCH 1785
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gral-20251016_lab.xml EX-101.LAB 22530
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gral-20251016_pre.xml EX-101.PRE 13045
20 EXTRACTED XBRL INSTANCE DOCUMENT gral-20251016_htm.xml XML 3120
Mailing Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025 (833) 694-2553
GRAIL, Inc. (Filer) CIK: 0001699031 (see all company filings)

EIN.: 863673636 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42045 | Film No.: 251398281
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)